Today's Issues continues on AFR with your host, Tim Wildman
>> Steve Jordahl: Today's Issues continues on AFR with your host, Tim Wildmon, president of the American Family Association.
>> Tim Wildmon: Hey, welcome back, everybody, to Today's Issues on American family Radio on this Thursday, June 4th. you're listening to AFR. I'm Tim with Fred Jackson and Ray Pritchard. And now joining us in studio for the last 24 and a half minutes of the show is Steve Paisley. Doradog.
>> Steve Jordahl: Hey, everybody.
>> Tim Wildmon: Steve.
>> Steve Jordahl: Hey.
>> Tim Wildmon: so, you know it's Fred's birthday.
>> Steve Jordahl: I do know it's Fred's birthday. I've been. I had a piece of cake.
>> Tim Wildmon: what did you. What did you get him?
>> Steve Jordahl: I got him a cup of coffee.
>> Tim Wildmon: Oh, that's right.
>> Fred Jackson: Yeah. Yes.
>> Tim Wildmon: Yeah.
>> Fred Jackson: Very kind.
>> Steve Jordahl: it's, Fred's tradition to treat us all to our favorite Starbucks drink on our birthday. So we figured we repay the,
>> Tim Wildmon: favor I got you. Okay. Good deal.
There is a new cancer drug that is, uh, making waves
Well, what's going on, Steve? We got some good news to report.
>> Steve Jordahl: We have some very good news to report. There is a new cancer drug that is, making. It's what they're calling a grand slam home run. So it's called Duraxan Razib. And just to tell you how different this is, you wouldn't think that you'd get a lot, of emotion out of a cancer, seminar, but I want to play you what happened, at a convention of cancer researchers when they talked about this drug. Play cut 14.
>> Tim Wildmon: The primary endpoint of the Rasulu 302 study evaluating overall survival in the Ras G12 population demonstrated a statistically significant improvement to the overall survival.
>> Steve Jordahl: That's a standing ovation that went on for minutes.
>> Fred Jackson: And it's for pancreatic cancer, right?
>> Tim Wildmon: One of the more deadly.
>> Steve Jordahl: One of the more deadly. So this is how it works. Cancers are basically cells that are stuck in the on position and keep growing and don't stop growing. There's a gene called KRAS gene that act. This is an on off switch which regulates that. It gets stuck on this drug is, what it basically does is it binds with that KRAS gene to shut down the cells that are growing. The gene that's stuck on it turns it off and keeps it off. So this is the result, the cancer among, just 13% of patients who get this diagnosis survive five years. Three percent. Only 3% survive five years or more when the disease is caught at an advanced stage, which it often is because it doesn't have early symptoms or there's no routine screening.
>> Tim Wildmon: We're talking again about pancreatic Pancreatic cancer.
>> Steve Jordahl: Pancreatic cancer.
>> Tim Wildmon: So this drug that you heard the. It was hard to pick up that audio. Yeah, that. What that was.
>> Steve Jordahl: There's a lot of medical talk. Anyway, I don't think you would have understood it, but,
>> Tim Wildmon: Yes, but I don't like to show off, but what you got there is, It's a professional convention of cancer researchers. Right. And probably oncologists and people. People who, do understand that profession. And a talk is being given by someone. Do you know the person?
>> Steve Jordahl: I don't know who is this researcher,
>> Tim Wildmon: but the talk is being given, and he's explaining what you just talked about. The success with this drug and slowing down or fighting back against it cuts
>> Steve Jordahl: the risk of death by 60%.
>> Tim Wildmon: That's what studies have shown.
>> Steve Jordahl: That's what the studies have shown.
>> Tim Wildmon: That's revolutionary.
>> Steve Jordahl: It is.
Tim Ferriss: A new drug is being tested for treating pancreatic cancer
>> Tim Wildmon: okay, so I want to play that again. I know it's hard to hear, but, can you tell us where this was? Well, place.
>> Steve Jordahl: I don't know. I don't know.
>> Tim Wildmon: The last few days.
>> Steve Jordahl: Yeah, the reason I brought it in was because of the standing ovation. What they're saying there, I wouldn't be able to explain to you.
>> Tim Wildmon: Right. I know it's. But they're giving a standing. These people are probably hard to get up out of their chairs.
>> Steve Jordahl: Right.
>> Tim Wildmon: Okay. They're. They're stoic scientists. Right. And researchers. And yet here we are, cheering like fans, at a football game.
>> Steve Jordahl: Right.
>> Tim Wildmon: Which is good to hear.
>> Steve Jordahl: Yeah.
>> Tim Wildmon: Because it's.
>> Steve Jordahl: It's impressing them.
>> Tim Wildmon: Yeah. Let's just play that one more time. The primary endpoint of the Raslute 302 study evaluating overall survival in the Ras G12 population demonstrated a statistically significant improve it. So, that story I found on the, On Daily Mail, it may be some other. I'm sure it's, of the Internet, all over the Internet.
>> Steve Jordahl: I have a NewSong York Post story on it here in front of me.
>> Tim Wildmon: Okay. Can we put that on our Today's Issues Facebook page? Brent is doing that so that people can read about it themselves because they may have family members that are dealing with this.
>> Steve Jordahl: Duraxan Razib is what the drug is called.
>> Fred Jackson: It's still in a, study stage, but very exciting. The results, it'll take a while. The FDA has to approve it.
>> Tim Wildmon: I mean, it's not available right now,
>> Fred Jackson: from what I've read. Is that the cancer cell, pancreatic cancer, the problem cell, has a very smooth surface, and the medications that they've used so far have not been able to, penetrate and bind through that smooth surface.
>> Tim Wildmon: Right.
>> Fred Jackson: But this new drug apparently is very successful at do it out. M. So it's exciting. It really is.
>> Tim Wildmon: Yeah. Right. Have you heard anything about. Have you heard about this? Yeah.
>> Tim Wildmon: And coming. Just coming at it from a personal point of view. I am so glad. I am so glad every time I hear about these breakthroughs, Tim. the whole field of immunotherapy is we are living in the age of medical miracles.
>> Fred Jackson: Yes.
>> Tim Wildmon: Coming down the pike on a. On an almost weekly basis. And this is big because pancreatic cancer, for such a long time, it was a death sentence. You got that. You didn't even. Typically, you weren't even diagnosed until late, and you didn't live very long. And so this drug has opened the door to give hope to folks like that. But they're making advances, Tim, with lung cancer and liver cancer and this glioblastoma that. So that affects the brain. So we are living in days, modern medical miracles. M. And I'm glad we can put this out for our listeners, because I bet some people will read this and take real hope.
>> Tim Wildmon: Amen.
>> Tim Wildmon: Good news on the way, friends.
>> Tim Wildmon: Maybe one day in the not too distant future, cancer will be eradicated.
>> Steve Jordahl: They're making Greece right now. Cancers are not all equal. I mean, they each have different treatments and such. Cancer isn't one thing.
>> Tim Wildmon: Cancer survival.
>> Tim Wildmon: Right. It's not one thing.
>> Tim Wildmon: It's not one thing. okay. It touches everybody. Okay. Everybody listening to me right now has either gone through themselves or had a family member or an extended family member or something Cancerous touch touches everybody in one way or another. Fred, you and Ray both had it.
>> Fred Jackson: Prostate.
>> Tim Wildmon: Yeah, prostate. Same thing, right?
>> Tim Wildmon: That's right.
>> Tim Wildmon: Same thing. my wife had Hodgkin's lymphoma. She is a cancer survivor from that. That's, a disease. That's cancer, that's very treatable if you catch it early enough. But I'm just saying. So there's a lot of advancements being made in the field of oncology and cancer treatment. And may God, as I said, his blessings to this research so that we can, save more people's lives.
Almost every cancer is treatable if it's caught soon enough
And the thing about some of the. But what I was going to. My ultimate point was cancer. Almost every cancer is treatable if it's caught soon enough. Problem with a lot of people is they, Well, with pancreatic cancer, I understand it's hard to have. Know your symptoms, right. Till. Till You. Till it's advanced to it. Too advanced. But, then a lot of people sadly don't go to an annual doctor's visit and don't and ignore symptoms and. And so you, what could have been caught, by even a routine physical, you know, where they do blood work and other things. At least, you know, you could have talked to a doctor. Wasn't. And so people just ignore things till it's, too far gone. But I would just. I would encourage everybody to go to the doctor. I'm talking about your general practitioner, once a year for what we used to call an annual physical. Everybody needs to do that. I think, Fred. Yeah.
>> Fred Jackson: You know, it's advisable.
>> Steve Jordahl: And the older you are, the more it's important.
>> Tim Wildmon: Catch a lot of things with the doctor looking you over and, blood work, basic blood work. And, you know, so there are some things that, you can do that are preventative, right?
>> Fred Jackson: That. That and lifestyle.
>> Tim Wildmon: Lifestyle, yes.
>> Fred Jackson: you know, there's.
>> Tim Wildmon: There's, for example, popcorn.
>> Tim Wildmon: Popcorn. Everybody knows. It's good for you.
>> Tim Wildmon: It's good for you. It's antioxidant.
>> Tim Wildmon: That's right.
>> Tim Wildmon: I agree. Diet. Diet means diet.
>> Fred Jackson: I've got a one big blueberry bush at my house. I'm enjoying that right now.
>> Steve Jordahl: There you go.
>> Fred Jackson: Blueberries are so good for superfood. Yep, it is.
>> Tim Wildmon: You guys. You're right. Now, what do you do with a person like me who I love tasteful food? Okay.
>> Fred Jackson: As opposed to tasteless.
>> Tim Wildmon: As opposed to distasteful food.
>> Tim Wildmon: Well, now, blueberries are tasty. There, There's. There are health food that are tasty. I, I agree with you, but I, That's not the first thing that enters my mind when it's time to eat is it's, that lasagna is awesome. And so. Yeah, but. But you. But I have learned.
>> Tim Wildmon: Sprinkle some blueberries on your lasagna.
>> Tim Wildmon: I have heart disease. Runs in my family, so I have to pay attention to that. And I do. I'm not. I don't go crazy with it. I do eat my share of broccoli and. And, you know, try to. Try to do that, but, But, But I don't.
>> Steve Jordahl: Everything in moderation.
>> Tim Wildmon: That's right. Like, like lasagna with extra meat sauce.
>> Tim Wildmon: That's right.
>> Tim Wildmon: I think extra meat sauce is. Is moderation.
Secretary of Homeland Security ran into Texas congressman during congressional hearing
All right, next story.
>> Steve Jordahl: All right, so the president's cabinet, generally one of their jobs is to go report to Congress and, our Secretary of Homeland Security, Mark Wayne Mullin went to the, House Committee on Homeland Security. He was given a report and he ran into a Texas congressman named Al Greene. Now you may have, you may remember Al Greene from the president's State of the Union address. He's the guy that's got kicked out two years in a row. When he stayed, he had a long career in music.
>> Tim Wildmon: Right. Al Greene. They spent the night together or something, like that. Wasn't that his hit?
>> Steve Jordahl: That was.
>> Tim Wildmon: Or if I got two, Al Greene.
>> Steve Jordahl: He might have a different Al Greene going. This was the Texas congressman. And you remember him from shaking his cane at the president and holding up the signs and everything?
>> Tim Wildmon: Yes, yes.
>> Steve Jordahl: Well, he was, he has been, he has. He lost a primary, so he has been voted out of Congress, but he's finishing up his term. And he's not in a very good mood and was not in a very good mood. He's got a cane and he's got a cane.
>> Tim Wildmon: Bad combo.
>> Steve Jordahl: Was not in a very good mood when he ran into Markway, Mullin, the Secretary of Homeland Security.
>> Tim Wildmon: They didn't physically run into each other, right?
>> Steve Jordahl: No hearing.
>> Tim Wildmon: This is a, ah, congressional hearing.
>> Steve Jordahl: It was, it was all but a physical confrontation. Cut six.
>> Tim Wildmon: Mr. Secretary would do. What happened to Ruby.
>> Steve Jordahl: Are you calling me a racist?
>> Tim Wildmon: A racist? I'm asking a question, reclaiming my time. Asking to shut up.
>> Fred Jackson: That's a pretty.
>> Tim Wildmon: Shut up. It's my time.
>> Steve Jordahl: I'm not gonna let anybody calls me
>> Tim Wildmon: call me a racist Chairman. I never called him a racist. It's my time. It is. Gentleman will suspend. He will not. Tell him to shut up. A gentleman suspend. No, the gentleman will suspend
>> Fred Jackson: mood.
>> Tim Wildmon: That's funny. Shut up. The gentleman.
>> Tim Wildmon: Shut up.
>> Tim Wildmon: The gentleman. The, juxtapot, juxt. What do you. What's that word? Position between the word gentleman and shut up is funny right there. It's not funny that, civility is lacking there.
Al Green called Homeland Security Secretary Mark Wayne Mullen a racist
No, but so Mark Wayne, the Secretary of Homeland Security, Mark Wayne Mullin, he former, senator from the state of Oklahoma.
>> Fred Jackson: Oklahoma.
>> Tim Wildmon: So he did, the guy call him a racist there?
>> Steve Jordahl: Well, yeah. So basically he was. A roundabout way. He was showing pictures of. This is what racists do. And he had a couple pictures of President Trump. And if you do this, you're a racist. One of the things is, he showed a picture of Mark Wayne Mullin, confronting another witness who happened, I think to be black. And so he was saying this is what racists do. And so why he didn't say, you are a racist. He was calling what he had done in the past Markoway Mullin racist.
>> Tim Wildmon: So what was the relevance to the, to Homeland Security? Because he's there to testify about what's going on in the work of the Homeland Security, which he took over for Kristi Noemi. And so that's he's doing. He's there to answer questions from
>> Steve Jordahl: the members of Congress.
>> Tim Wildmon: Members of Congress. And this guy goes off on racism.
>> Steve Jordahl: Yeah.
>> Tim Wildmon: And what did that have to do with anything?
>> Steve Jordahl: Absolutely nothing. And as we've seen, I don't know if we, how many we played on the air. We certainly have reviewed quite a bit in our meetings. oftentimes senators come prepared with clips, that their staff thinks are going to get them. Social media, you know, clicks. and so Al Greene was just being Al Greene. He's just kind of perpetually.
>> Tim Wildmon: Yeah, everybody's seen him if you, even if you don't know what his name is. But interesting. He lost in a Democrat primary.
>> Steve Jordahl: He did.
>> Tim Wildmon: Is he from Houston?
>> Steve Jordahl: Yes.
>> Fred Jackson: It was a redistrict issue. One of those things. You know, it's a favorite tactic of the Democratic Party. they like to throw out the word racist. You know, we've had this confrontation going on at the detention center in NewSong Jersey over the last couple of weeks. You've had the rent a crowd out there and of course somebody in that crowd's going to say you're racist because you're holding people from an Hispanic background.
>> Tim Wildmon: Right. It's an ICE detention center. Right.
>> Fred Jackson: It's an ICE detention center. It gets really crazy. There were some Democrats, the other day, there's a story out there saying isn't it horrible that these people being kept at the detention center, they're being separated from their children.
>> Tim Wildmon: Well when you break the law that's what happens.
>> Fred Jackson: You go to jail. Your kids don't go to jail with you.
>> Tim Wildmon: Right.
>> Fred Jackson: That happens. But the mainstream media just loves the mainstream media for the most part. I mean they are in bed with the Democratic Party, period. That's, that's where it is today. Without apology.
>> Tim Wildmon: Yeah.
Protesters in Minnesota stormed a church Sunday, disrupting worship service
Next story. Steve.
>> Steve Jordahl: All, right. Do you remember back in January when protesters in Minnesota stormed city ah, Church in St. Paul.
>> Tim Wildmon: Yes.
>> Steve Jordahl: Including the
>> Tim Wildmon: Why did they do that?
>> Steve Jordahl: Well they, the one of the pastors at City's church also was a member of ice. He was an ICE agent or maybe part time job. Part time jobs with ice and of course anything. ICE was they were protesting. So they walked into a worship service Sunday morning and started yelling in the middle of the worship service. Well, St. Paul's City Attorney has reviewed all the relevant records and found. Well, I guess we don't have enough evidence that there was a crime committed, so we are going to drop all the charges. City of St. Paul thinks you have as much right to crash a church service, take it over, scream at the families as you do to attend a church service. So they got things a little bit backwards now. This is the city of St. Paul. There are still federal charges that are pending with regard to this protest under the FACE Act. Under the FACE Act? The Freedom of Access to Clinic Entrances Act.
>> Fred Jackson: Yes.
>> Steve Jordahl: But they have dismissed this. As far as Minnesota, crimes,
>> Fred Jackson: if I was a betting man, if it was a mob that went into a, Islamic gathering.
>> Tim Wildmon: Oh man.
>> Steve Jordahl: Mosque.
>> Fred Jackson: Yeah. Do you. Do you think the charges would be dismissed?
>> Tim Wildmon: No way.
>> Fred Jackson: It wouldn't happen. It wouldn't happen.
>> Tim Wildmon: Now, did they actually vandalize or attack people physically? And what I saw from the video was they were. A few of them were shouting at the parishioners inside a church gathering, which is appalling. And it does violate, the words of the Face act, which was, which we don't have time to go into, which is a federal law. But did they.
>> Steve Jordahl: There was no physical conference. There was no physical contact. They just, Just disrupting the worship.
>> Tim Wildmon: Then what would you charge them with?
>> Steve Jordahl: disrupting a, Trespassing.
>> Tim Wildmon: They've been. But they've been dismissed of all charges.
>> Steve Jordahl: Yes.
>> Fred Jackson: By the state. By the state.
>> Tim Wildmon: By the state of Minnesota. Yeah. But to your point, Fred, if they were. If this were a bunch of, let's say, white evangelicals, m. White men who went into a mosque and started shouting down the, attendees in the middle of their, worship service. Their. Their M. Muslim worship service, whatever they call that, I'm not sure. Gathering, that it would have made national news. And the,
>> Tim Wildmon: Go right to jail.
>> Tim Wildmon: They go right to jail. Don't go past. Go. Don't collect $200. Right.
>> Fred Jackson: No question.
>> Tim Wildmon: Especially Minnesota. Oh, yeah. So, anyway.
>> Tim Wildmon: So it's okay. It's okay to disrupt the worship service?
>> Tim Wildmon: Yeah.
>> Tim Wildmon: In Minnesota, as long as you don't physically hurt somebody. It's okay to disrupt a Christian worship.
>> Tim Wildmon: That's what they've said here.
>> Steve Jordahl: And protesters have continued to go back to this church. Now, they're not going in during the service, but they are shouting at families who are walking church and in front of their children and calling them names and Just.
>> Tim Wildmon: Yeah, because one of the pastors is a part time ICE agent. That's the reason they went in there. Right. This was during the height of the. Remember, the two people were killed and yeah, a lot of, lot of ugly confrontations in the street as the ICE agents were threatened and they went. That's what led to the deaths of these, the two people. But basically you had a very liberal, activist in Minneapolis St. Paul area who did not want to see ICE, arresting anybody for any reason, even though they were coming after drug dealers and sex, offenders and all kind of people that, that people who had warrants and it, but that didn't matter. ice, if you. The. These people, bizarrely won't. Don't want any deportations at all. They won't. They won't. They want everybody. If you get here, it doesn't matter what kind of person you are, what kind of criminal activity you're in this branch of the Democrat Party. Not all of them, they want them all to be able to stay and carry on and not be arrested.
>> Fred Jackson: It's interesting. To your point?
>> Tim Wildmon: Yeah.
Georgia is asking people to kill four foot long lizards
>> Fred Jackson: Karen Bass the other night, she's the mayor of Los Angeles and she'll likely continue to be the mayor of Los Angeles. in her speech after the results started coming in, she said, we are all Angelenos. We don't care where you came from or how you got here.
>> Tim Wildmon: Right.
>> Fred Jackson: What was she saying? Yeah, we don't care if you're in the country illegally.
>> Tim Wildmon: No, that doesn't.
>> Fred Jackson: We don't care if you broke in.
>> Tim Wildmon: Right.
>> Fred Jackson: You're one of us.
>> Tim Wildmon: Right.
>> Fred Jackson: And that's the thinking of whether it's the mayor of Chicago or the mayor of NewSong York City. You know, that's their thinking. They don't care whether you broke into the country.
>> Tim Wildmon: Well, they don't believe in borders. So, anyway. Go ahead, Steve. We got about three minutes left here.
>> Steve Jordahl: if you are in Georgia, you might run into a four foot long lizard. The state is asking you to catch it and kill it. But if you do, it's non, native, it's invasive and it tends, to eat, things that they need to keep. They don't.
>> Tim Wildmon: Right.
>> Tim Wildmon: How, how are, How, Steve, are we to. How are we to catch a four foot lizard?
>> Steve Jordahl: Very carefully. Like, you go first, I'll watch with a lizard.
>> Tim Wildmon: I don't know, I don't know about this.
>> Steve Jordahl: but they're called the black and white tegu and you're supposed to kill them. So I suppose a handgun or a rifle work.
>> Tim Wildmon: Rednecks can kill almost any critter.
>> Steve Jordahl: That's true.
>> Tim Wildmon: That's right. I think where these lizards come from.
>> Steve Jordahl: Native South America. I don't know how they got here,
>> Tim Wildmon: but somebody brought them up here and dropped them off. Dropped a few of them off in the woods. I, think.
>> Tim Wildmon: Well, if they got them in Georgia, don't you think we got them in Florida?
>> Tim Wildmon: Oh, yeah, you do. They don't believe in borders.
>> Steve Jordahl: They probably.
>> Tim Wildmon: That's right, they do.
>> Steve Jordahl: I don't believe in borders. Here's what I'm guessing happened. Somebody went, some local pet store owner got these two lizards which were probably at the time six inches long. And somebody said, oh, that'd be a great pet. And they got to be two feet, three feet, about three and a half feet. They said, I can't do this. They just kind of let them loose in the backyard.
>> Tim Wildmon: And now there it is. What kind of lizards are they? They're three or four feet long, right.
>> Steve Jordahl: Up to four feet long. And they're called black and white Tegu t e g U lizards. They can weigh more than.
>> Tim Wildmon: They're native to what, South America?
>> Steve Jordahl: They're native to South America, but they've been found in tombs in Tattenal counties in south. In southeast Georgia.
>> Tim Wildmon: I don't like any part of this story
>> Tim Wildmon: as an. As a near full time Floridian, you know?
>> Tim Wildmon: That's right.
>> Steve Jordahl: What I don't know, Ray, is if when it gets cold, they fall from trees or not. That would be iguanas.
>> Tim Wildmon: Iguanas are about What? They're about 6 or 8 inches long, typically. Right. They're not.
>> Steve Jordahl: They can be bigger than that.
>> Tim Wildmon: They can be bigger than that. what'd you say, Fred?
>> Fred Jackson: Yeah. No.
>> Tim Wildmon: Yeah. Growing up in Canada, he didn't have to deal with all these lizards. No iguanas and stuff like that.
>> Fred Jackson: but they're smart. They don't go to Canada because they freeze.
>> Tim Wildmon: That's right.
Sam: It'll have be trivia Friday tomorrow on this show
all right, we're out of time. tomorrow's trivia. So we'll. It'll have be trivia Friday tomorrow here on this show today. Ah, let's see. J.J. will be here. I think Ed's. Ed's out.
>> Steve Jordahl: Ed's got a Jonathan's in.
>> Tim Wildmon: Right. Attitude problem. So I don't know, but J.J. will be here. He's in good spirits. We'll see you back here tomorrow,
>> Tim Wildmon: Sam.
